PMI (NYSEAMERICAN:PMI) Raised to “Hold” at Zacks Research

PMI (NYSEAMERICAN:PMI) was upgraded by research analysts at Zacks Research to a “hold” rating in a report issued on Tuesday,Zacks.com reports.

Separately, HC Wainwright assumed coverage on shares of PMI in a research report on Monday. They set a “neutral” rating for the company. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

PMI Stock Performance

NYSEAMERICAN:PMI opened at $0.15 on Tuesday. PMI has a twelve month low of $0.13 and a twelve month high of $13.68. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.75 and a quick ratio of 0.72. The firm’s 50-day simple moving average is $0.78.

PMI (NYSEAMERICAN:PMI) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.10) earnings per share for the quarter. The firm had revenue of $1.15 million for the quarter. Analysts forecast that PMI will post -0.17 earnings per share for the current year.

Key Stories Impacting PMI

Here are the key news stories impacting PMI this week:

• Neutral Sentiment: HC Wainwright reiterated a Neutral stance on PMI while publishing updated estimates across 2026 and 2027, including projected losses in every period and full-year EPS of ($0.17) for FY2026 and ($0.09) for FY2027. PMI analyst coverage
• Neutral Sentiment: The most recent quarterly results also showed PMI remained unprofitable, with the company posting ($0.10) EPS on $1.15 million in revenue, reinforcing concerns about near-term profitability. PMI earnings results
• Negative Sentiment: Multiple analyst forecasts for the next several quarters point to continued losses, which can weigh on investor sentiment and keep pressure on the stock. PMI earnings estimates

PMI Company Profile

Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.